Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 19Neoplasms 18Cancer Pain 6Breast Neoplasms 5Breakthrough Pain 5Prostatic Neoplasms 4Lung Neoplasms 4Colonic Neoplasms 4Agnosia 4Rectal Neoplasms 3Pancreatic Neoplasms 3Head and Neck Neoplasms 3Chronic Pain 3Uterine Cervical Neoplasms 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain, Postoperative 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Burns 2Anemia, Sickle Cell 2post laminectomy syndrome 1Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vipoma 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1

Interventions

Ketamine 2substance P-saporin 1Infusion Pumps, Implantable 1Fentanyl 1Dexmedetomidine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pain, Intractable × Fentanyl × Clear all
NCT00216658 2011-01-24

Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -

Janssen Pharmaceutical K.K.

Phase 2 Completed
87 enrolled

Cancer Pain, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡